DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Phosphatidylinositol signaling system	R-HSA-1280215	map04070	deferoxamine	5288674	drug-path
Autoimmune thyroid disease	R-HSA-1643685	map05320	deferoxamine	5288674	drug-path
Huntington's disease	R-HSA-1643685	0	deferoxamine	5288674	drug-path
Olfactory transduction	R-HSA-9751605	map04740	deferoxamine	5288674	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	deferoxamine	5288674	drug-path
Bladder cancer	R-HSA-9700206	map05219	deferoxamine	5288674	drug-path
p53 signaling pathway	R-HSA-168638	map04115	deferoxamine	5288674	drug-path
Parkinson's disease	R-HSA-1643685	0	deferoxamine	5288674	drug-path
Ribosome	R-HSA-5368277	map03010	deferoxamine	5288674	drug-path
Allograft rejection	R-HSA-9679028	map05330	deferoxamine	5288674	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	deferoxamine	5288674	drug-path
Alzheimer's disease	R-HSA-1643685	0	deferoxamine	5288674	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	deferoxamine	5288674	drug-path
Insulin signaling pathway	R-HSA-74752	map04910	deferoxamine	5288674	drug-path
Focal adhesion	R-HSA-354113	map04510	deferoxamine	5288674	drug-path
Circadian rhythm - mammal	R-HSA-400253	0	deferoxamine	5288674	drug-path
Pancreatic cancer	R-HSA-9700206	map05212	deferoxamine	5288674	drug-path
Prostate cancer	R-HSA-2990872	map05215	deferoxamine	5288674	drug-path
Tight junction	R-HSA-2134514	map04530	deferoxamine	5288674	drug-path
Long-term potentiation	R-HSA-9620244	map04720	deferoxamine	5288674	drug-path